-
1
-
-
67649240629
-
Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: Population based case-control study
-
Doi: 10.1136/bmj.b929
-
Islami F, Pourshams A, Nasrollahzadeh D, et al.: Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ 2009; 338: b929. Doi: 10.1136/bmj.b929
-
(2009)
BMJ
, vol.338
-
-
Islami, F.1
Pourshams, A.2
Nasrollahzadeh, D.3
-
2
-
-
60549093408
-
Thymidine phosphorylase expression and benefit from capecitabine in patients with advanced breast cancer
-
Andreetta C, Puppin, C, Minisini A, et al.: Thymidine phosphorylase expression and benefit from capecitabine in patients with advanced breast cancer. Annals of Oncology 2009; 20: 265-71.
-
(2009)
Annals of Oncology
, vol.20
, pp. 265-271
-
-
Andreetta, C.1
Puppin, C.2
Minisini, A.3
-
3
-
-
0032880659
-
Aspekte der statistischen Evaluation neuer Prognosefaktoren: Illustration bei Studien in der Onkologie
-
Sauerbrei W, Schumacher M: Aspekte der statistischen Evaluation neuer Prognosefaktoren: Illustration bei Studien in der Onkologie. Geburtshilfe und Frauenheilkunde 1999; 59: 483-7.
-
(1999)
Geburtshilfe und Frauenheilkunde
, vol.59
, pp. 483-487
-
-
Sauerbrei, W.1
Schumacher, M.2
-
9
-
-
0028179558
-
Dangers of using "optimal" cutpoints in the evaluation of prognostic factors
-
Altman DG, Lausen B, Sauerbrei W, Schumacher M: Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J Net Cancer Inst 1994; 86: 829-35.
-
(1994)
J Net Cancer Inst
, vol.86
, pp. 829-835
-
-
Altman, D.G.1
Lausen, B.2
Sauerbrei, W.3
Schumacher, M.4
-
11
-
-
0029739639
-
Interaction 1: Heterogeneity of effects
-
Altman DG, Matthews JNS: Interaction 1: heterogeneity of effects. BMJ 1996; 313: 486.
-
(1996)
BMJ
, vol.313
, pp. 486
-
-
Altman, D.G.1
Matthews, J.N.S.2
-
12
-
-
0034712491
-
Subgroup analysis and other (mis)uses of baseline data in clinical trials
-
Assmann SF, Pocock SJ, Enos LE, Kasten LE: Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet 2000; 355: 1064-9.
-
(2000)
Lancet
, vol.355
, pp. 1064-1069
-
-
Assmann, S.F.1
Pocock, S.J.2
Enos, L.E.3
Kasten, L.E.4
-
13
-
-
36348939350
-
Statistics in medicine - Reporting of subgroup analyses in clinical trials
-
Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM: Statistics in medicine - reporting of subgroup analyses in clinical trials. The New England Journal of Medicine 2007; 357: 2189-94.
-
(2007)
The New England Journal of Medicine
, vol.357
, pp. 2189-2194
-
-
Wang, R.1
Lagakos, S.W.2
Ware, J.H.3
Hunter, D.J.4
Drazen, J.M.5
-
14
-
-
70349881514
-
Deskriptive Statistik
-
Spriestersbach A, Gerhold-Ay A, du Prel JB, Röhrig B, Blettner M: Deskriptive Statistik. Dtsch Arztebl Int 2009; 106(36): 578-83.
-
(2009)
Dtsch Arztebl Int
, vol.106
, Issue.36
, pp. 578-583
-
-
Spriestersbach, A.1
Gerhold-Ay, A.2
Du Prel, J.B.3
Röhrig, B.4
Blettner, M.5
|